INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

70,213 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
FD
Francisco DavidChief Financial Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
43.6K sh
Feb 18, 2026Feb 20, 2026
Page 1240 of 1756
← PrevNext →
traded Feb 18, 2026
+2d
SEC Form 4

Evidence

13
NE
Nursey Michael E.See remarks
AMTBAmerant Bancorp Inc.
Tax withholding
F$4,185
187 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
SA
Sandler ArielChief Operations Officer
PLTKPlaytika Holding Corp.
Grant or award
A—
47.4K sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

13
GB
Grow BrianChief Commercial Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
48.3K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
CS
Calderon SharymarSEVP - Chief Financial Officer
AMTBAmerant Bancorp Inc.
Option exercise
M—
2,490 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
HJ
Hogge JeromeEVP, Chief Operating Officer
CTEVClaritev Corp
Grant or award
A—
8,723 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
DL
Dietrich LisaEVP, CDIO
LECOLINCOLN ELECTRIC HOLDINGS INC
Grant or award
A—
513 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
PR
Purdue David RyanSVP, Controller
ABBVAbbVie Inc.
Grant or award
A—
1,292 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
SC
Siatis Perry CEVP, GC AND SECRETARY
ABBVAbbVie Inc.
Grant or award
A—
5,808 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
MS
Montecalvo Antonio S.Vice President, Health Policy
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
11.2K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
RA
Rodriguez AdrianSee remarks
AMTBAmerant Bancorp Inc.
Option exercise
M—
833 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
DE
Delaney Mark ESVP & Chief Commercial Officer
DGXQUEST DIAGNOSTICS INC
Grant or award
A—
1,586 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
PR
Purdue David RyanSVP, Controller
ABBVAbbVie Inc.
Grant or award
A—
890 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
CD
Crum Demetris DEVP, CHIEF HR OFFICER
ABBVAbbVie Inc.
Grant or award
A—
1,244 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
EJ
Eelman Anthony J.EVP, Chief Products Officer
AMTBAmerant Bancorp Inc.
Tax withholding
F$2,216
99 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
SA
Sandler ArielChief Operations Officer
PLTKPlaytika Holding Corp.
Grant or award
A—
47.4K sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

13
TR
Thakkar RoopalEVP, R&D and CSO
ABBVAbbVie Inc.
Grant or award
A—
6,015 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
SM
Sanchez MariolaSee remarks
AMTBAmerant Bancorp Inc.
Option exercise
M—
1,740 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
TR
Thakkar RoopalEVP, R&D and CSO
ABBVAbbVie Inc.
Grant or award
A—
3,346 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
CR
Cavorsi RobertVice President, Strategy
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
16.3K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

12
MD
Maday DavidChief Financial Officer
AURAurora Innovation, Inc.
Tax withholding
F$190K
39.1K sh
Feb 20, 2026Feb 20, 2026
traded Feb 20, 2026
+0dSEC Form 4

Evidence

12
ND
Newell Clifford Doyle IIIChief Commercial Officer
CRKCOMSTOCK RESOURCES INC
Tax withholding
F$71K
3,591 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

12
TK
Talluri Rajendra KDirector, President and CEO
ENVXEnovix Corp
Tax withholding
F$105K
17.6K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

12
NR
Nielsen Iii RobertSR VP Operations
WCNWaste Connections, Inc.
Tax withholding
F$51K
316 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

12
KK
Kuppusamy KarthikSVP, Clinical Solutions
DGXQUEST DIAGNOSTICS INC
Tax withholding
F$54K
259 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

12
BP
Bilbo PatrickChief Operating Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$62K
16.2K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

12
FL
Freedman LoriChief Admin. and Legal Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$55K
14.3K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

12
FD
Francisco DavidChief Financial Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$56K
14.5K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

12
CS
Cohen StephenSenior Managing Director
BLKBlackRock, Inc.
Gift
G—
657 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

12
KK
Kuppusamy KarthikSVP, Clinical Solutions
DGXQUEST DIAGNOSTICS INC
Tax withholding
F$53K
252 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

11
CW
Chatterjee WhitneyChief Legal Officer
APOApollo Global Management, Inc.
Tax withholding
F$649K
4,899 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

11
SK
Subaiya Thimaya K.EVP, Operations
CSCOCISCO SYSTEMS, INC.
Open-market sale · 10b5-1 plan
SELL$662K
8,433 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

10
RW
Rogers James WilliamChief Financial Officer
TEMTempus AI, Inc.
Grant or award
A—
37.5K sh
Feb 20, 2026Feb 20, 2026
traded Feb 20, 2026
+0dSEC Form 4

Evidence

9
FD
Francisco DavidChief Financial Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
111.4K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

9
VY
van der Laan YvonneEVP, Circular & Low Carbon Sol
LYBLyondellBasell Industries N.V.
Grant or award
A$16K
289 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

9
MA
Morton Jessica AnnSVP, Gen Counsel, Secretary
ROGROGERS CORP
Tax withholding
F$42K
374 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

9
IA
Izquierdo Sabido AgustinEVP & Chief Financial Officer
LYBLyondellBasell Industries N.V.
Grant or award
A$4,310
77 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

9
MA
Morrison AnneEVP, CAO & General Counsel
ESSESSEX PROPERTY TRUST, INC.
Tax withholding
F$23K
89 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

9
CM
Castle Angela MVP & Chief Legal Officer
OLNOLIN Corp
Grant or award
A—
16.0K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

9
CD
Campbell Tracey DEVP, Sustainability & Corp Aff
LYBLyondellBasell Industries N.V.
Tax withholding
F$9,627
172 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence